CD44 Predisposes the Epileptogenesis of Cortical Tubers by Regulating CASK and Acts as a Potential Biomarker to Identify Epileptogenic Tuber in Tuberous Sclerosis Complex
Zhongke Wang,
Kaixuan Huang,
Xingye Liu,
Yang Li,
Shujing Li,
Jie Li,
Hu Li,
Jingze Wang,
Zeng He,
Limeng Sun,
Yali Cheng,
Ruotong Ruan,
Zhonghong Liu,
Shengqing Lv,
Chunqing Zhang,
Hui Yang,
Xiaolin Yang,
Shiyong Liu CNS Neuroscience and Therapeutics
· Wiley
· 2026-11-10
· DOI: 10.1002/cns.71262
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Zhongke Wang, Kaixuan Huang, Xingye Liu, Yang Li, Shujing Li, Jie Li et al. CD44 Predisposes the Epileptogenesis of Cortical Tubers by Regulating CASK and Acts as a Potential Biomarker to Identify Epileptogenic Tuber in Tuberous Sclerosis Complex. // CNS Neuroscience and Therapeutics. – 2026. – DOI: 10.1002/cns.71262. – URL: https://onlinelibrary.wiley.com/doi/10.1002/cns.71262?af=R
Zhongke Wang, Kaixuan Huang, Xingye Liu, Yang Li, Shujing Li, Jie Li, Hu Li, Jingze Wang, Zeng He, Limeng Sun, Yali Cheng, Ruotong Ruan, Zhonghong Liu, Shengqing Lv, Chunqing Zhang, Hui Yang, Xiaolin Yang, & Shiyong Liu (2026). CD44 Predisposes the Epileptogenesis of Cortical Tubers by Regulating CASK and Acts as a Potential Biomarker to Identify Epileptogenic Tuber in Tuberous Sclerosis Complex. CNS Neuroscience and Therapeutics. https://doi.org/10.1002/cns.71262
Zhongke Wang, et al. “CD44 Predisposes the Epileptogenesis of Cortical Tubers by Regulating CASK and Acts as a Potential Biomarker to Identify Epileptogenic Tuber in Tuberous Sclerosis Complex.” CNS Neuroscience and Therapeutics, 2026. doi:10.1002/cns.71262.
@article{Wang2026,
title = {CD44 Predisposes the Epileptogenesis of Cortical Tubers by Regulating CASK and Acts as a Potential Biomarker to Identify Epileptogenic Tuber in Tuberous Sclerosis Complex},
author = {Wang, Zhongke and Huang, Kaixuan and Liu, Xingye and Li, Yang and Li, Shujing and Li, Jie and Li, Hu and Wang, Jingze and He, Zeng and Sun, Limeng and Cheng, Yali and Ruan, Ruotong and Liu, Zhonghong and Lv, Shengqing and Zhang, Chunqing and Yang, Hui and Yang, Xiaolin and Liu, Shiyong},
journal = {CNS Neuroscience and Therapeutics},
year = {2026},
doi = {10.1002/cns.71262},
url = {https://onlinelibrary.wiley.com/doi/10.1002/cns.71262?af=R}
}
ABSTRACT Introduction/Aims Pompe disease is a genetic myopathy caused by acid alpha‐glucosidase enzyme deficiency. Treatment response is mainly evaluated using motor scores, for instance the 6‐min walk test (6MWT) or the Motor Function...
ABSTRACT Introduction/Aims Inflammatory neuropathies (IN), such as Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), are characterized by peripheral nerve injury driven by immune...